Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2 RD Jiang, MQ Liu, Y Chen, C Shan, YW Zhou, XR Shen, Q Li, L Zhang, ... Cell 182 (1), 50-58. e8, 2020 | 551 | 2020 |
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells S Wang, Z Qiu, Y Hou, X Deng, W Xu, T Zheng, P Wu, S Xie, W Bian, ... Cell research 31 (2), 126-140, 2021 | 449 | 2021 |
Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes Y Liu, J Liu, S Du, C Shan, K Nie, R Zhang, XF Li, R Zhang, T Wang, ... Nature 545 (7655), 482-486, 2017 | 383 | 2017 |
An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors C Shan, X Xie, AE Muruato, SL Rossi, CM Roundy, SR Azar, Y Yang, ... Cell host & microbe 19 (6), 891-900, 2016 | 303 | 2016 |
An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction H Xia, H Luo, C Shan, AE Muruato, BTD Nunes, DBA Medeiros, J Zou, ... Nature communications 9 (1), 414, 2018 | 292 | 2018 |
A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models C Shan, AE Muruato, BTD Nunes, H Luo, X Xie, DBA Medeiros, ... Nature medicine 23 (6), 763-767, 2017 | 283 | 2017 |
Vaccine mediated protection against Zika virus-induced congenital disease JM Richner, BW Jagger, C Shan, CR Fontes, KA Dowd, B Cao, ... Cell 170 (2), 273-283. e12, 2017 | 276 | 2017 |
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques C Shan, YF Yao, XL Yang, YW Zhou, G Gao, Y Peng, L Yang, X Hu, ... Cell research 30 (8), 670-677, 2020 | 266 | 2020 |
Zika virus has oncolytic activity against glioblastoma stem cells Z Zhu, MJ Gorman, LD McKenzie, JN Chai, CG Hubert, BC Prager, ... Journal of Experimental Medicine 214 (10), 2843-2857, 2017 | 244 | 2017 |
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques L Feng, Q Wang, C Shan, C Yang, Y Feng, J Wu, X Liu, Y Zhou, R Jiang, ... Nature communications 11 (1), 4207, 2020 | 222 | 2020 |
Molecular signatures associated with ZIKV exposure in human cortical neural progenitors F Zhang, C Hammack, SC Ogden, Y Cheng, EM Lee, Z Wen, X Qian, ... Nucleic acids research 44 (18), 8610-8620, 2016 | 181 | 2016 |
Functional analysis of glycosylation of Zika virus envelope protein CR Fontes-Garfias, C Shan, H Luo, AE Muruato, DBA Medeiros, E Mays, ... Cell reports 21 (5), 1180-1190, 2017 | 160 | 2017 |
A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage C Shan, AE Muruato, BW Jagger, J Richner, BTD Nunes, DBA Medeiros, ... Nature communications 8 (1), 676, 2017 | 152 | 2017 |
Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network MT Aliota, L Bassit, SS Bradrick, B Cox, MA Garcia-Blanco, C Gavegnano, ... Antiviral research 144, 223-246, 2017 | 134 | 2017 |
Zika virus: diagnosis, therapeutics, and vaccine C Shan, X Xie, ADT Barrett, MA Garcia-Blanco, RB Tesh, ... ACS Infectious Diseases 2 (3), 170-172, 2016 | 118 | 2016 |
Dengue subgenomic flaviviral RNA disrupts immunity in mosquito salivary glands to increase virus transmission J Pompon, M Manuel, GK Ng, B Wong, C Shan, G Manokaran, ... PLoS pathogens 13 (7), e1006535, 2017 | 115 | 2017 |
Human IFIT3 modulates IFIT1 RNA binding specificity and protein stability B Johnson, LA VanBlargan, W Xu, JP White, C Shan, PY Shi, R Zhang, ... Immunity 48 (3), 487-499. e5, 2018 | 110 | 2018 |
Zika virus vaccine: progress and challenges C Shan, X Xie, PY Shi Cell host & microbe 24 (1), 12-17, 2018 | 104 | 2018 |
Envelope protein ubiquitination drives entry and pathogenesis of Zika virus MI Giraldo, H Xia, L Aguilera-Aguirre, A Hage, S van Tol, C Shan, X Xie, ... Nature 585 (7825), 414-419, 2020 | 103 | 2020 |
Discovery of dengue virus NS4B inhibitors QY Wang, H Dong, B Zou, R Karuna, KF Wan, J Zou, A Susila, A Yip, ... Journal of virology 89 (16), 8233-8244, 2015 | 95 | 2015 |